Bacfo Pharmaceuticals (India ) Limited, a active public limited company, was established on 20 October 1994 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74899DL1994PLC062272. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹2.61 Cr.
It upholds a compliant status. Employing 160 professional, Its leadership includes Achal Kumar Chauhan (Additional Director), Rajesh Puri (Director), Arun Chauhan (Managing Director). Past directors included Abhishek Chauhan, Surendra Kumar. It holds ₹27.10 Cr open charges and ₹8.61 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at E-27, Defence Colony Ring Road Defence Colony, New Delhi, Delhi, 110024.
U74899DL1994PLC062272
062272
20 October 1994
₹4.00 Cr
₹2.61 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Bacfo Pharmaceuticals (India ) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Achal Kumar Chauhan | Additional Director | 07 Mar 2013 | Current |
| Rajesh Puri | Director | 01 Jul 2006 | Current |
| Arun Chauhan | Managing Director | 21 Oct 1994 | Current |
| Akhil Chauhan | Director | 28 Dec 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 03 Nov 2014 | Past |
| Pramod Abcsdd | Director | 26 Aug 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bacfo Pharmaceuticals (India ) Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 2.49% decrease. The company also saw a substantial fall in profitability, with a 40.78% decrease in profit. The company's net worth Soared by an impressive increase of 18.16%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Bacfo Pharmaceuticals (India ) had a promoter holding of 86.59% and a public holding of 13.41%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹271,018,000.00
₹86,050,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2022 | Axis Bank Limited | ₹3.00 Cr | Open |
| 26 Aug 2022 | Hdfc Bank Limited | ₹3.35 M | Open |
| 30 Apr 2022 | Axis Bank Limited | ₹6.00 Cr | Open |
| 17 Feb 2022 | Axis Bank Limited | ₹1.44 Cr | Open |
| 13 Oct 2021 | Axis Bank Limited | ₹4.00 Cr | Open |
Explore comprehensive loan charge details -
Bacfo Pharmaceuticals (India ) has a workforce of 160 employees as of Mar 31, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Bacfo Pharmaceuticals (India ), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bacfo Pharmaceuticals (India )'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Bacfo Pharmaceuticals (India ) Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Bacfo Pharmaceuticals (India ) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
A charge with Axis Bank Limited of Rs. 8.18 Cr registered on 31 Jan 2020 with Charge ID 100323373 was modified on 10 Sep 2024. was recorded as a recent event.
Progress on A charge with Axis Bank Limited amounted to Rs. 3.00 Cr with Charge ID 100651541 was registered on 21 Nov 2022. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 0.33 Cr with Charge ID 100610832 was registered on 26 Aug 2022. was recorded as a recent event.
The activity A charge with Axis Bank Limited amounted to Rs. 6.00 Cr with Charge ID 100574605 was registered on 30 Apr 2022. was completed.
The CIN of Bacfo Pharmaceuticals (India ) Limited is U74899DL1994PLC062272.
Bacfo Pharmaceuticals (India ) Limited is headquartered at E-27, Defence Colony Ring Road Defence Colony, New Delhi, Delhi, 110024.
Bacfo Pharmaceuticals (India ) Limited was incorporated on 20 October 1994.
The current directors of Bacfo Pharmaceuticals (India ) Limited are
The primary industry of Bacfo Pharmaceuticals (India ) Limited is Manufacturing.
Bacfo Pharmaceuticals (India ) Limited is unlisted.
The authorized capital of Bacfo Pharmaceuticals (India ) Limited is ₹4.00 Cr, and the paid-up capital is ₹2.61 Cr.
The compliance status of Bacfo Pharmaceuticals (India ) Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX